Search results for "Response"

showing 10 items of 4136 documents

Butyrate, a postbiotic of intestinal bacteria, affects pancreatic cancer and gemcitabine response in in vitro and in vivo models

2022

Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer. The characteristic excessive stromatogenesis accompanying the growth of this tumor is believed to contribute to chemoresistance which, together with drug toxicity, results in poor clinical outcome. An increasing number of studies are showing that gut microbiota and their metabolites are implicated in cancer pathogenesis, progression and response to therapies. In this study we tested butyrate, a product of dietary fibers' bacterial fermentation, whose anticancer and anti-inflammatory functions are known. We provided in vitro evidence that, beside slowing proliferation, butyrate enhanced gemcitabine effectiveness against two hum…

PharmacologyBacteriaMicrobiotaPancreatic cancerGeneral MedicineSettore MED/08 - Anatomia PatologicaDeoxycytidineGemcitabinePancreatic NeoplasmsButyratesMiceCell Line TumorAnimalsGemcitabine responseCarcinoma Pancreatic DuctalBiomedicine & Pharmacotherapy
researchProduct

Common and separable behavioral and neural mechanisms underlie the generalization of fear and disgust

2021

Generalization represents the transfer of a conditioned responses to stimuli that resemble the conditioned stimulus (CS). Previous studies on generalization of defensive avoidance responses have primarily focused on fear and have neglected disgust generalization, which represents a key pathological mechanism in some anxiety disorders. In the present study we examined common and distinct mechanisms of fear and disgust generalization by means of a fear or disgust multi-CS conditioning and generalization paradigm with concomitant event-related potential (ERPs) acquisition in n = 62 subjects. We demonstrate that compared to fear, disgust-relevant generalized stimuli (GS) elicited larger expecta…

PharmacologyConditioning Classicaldisgustdefensive responsesFearevent-related potentialsAnxiety DisordersGeneralization Psychologicalhumanitiespuolustusmekanismit (psykologia)ehdollistuminenyleistäminenmulti-conditioned stimulus conditioninginhoahdistuneisuushäiriötHumansfearpelkovälttämisreaktiotBiological PsychiatryärsykkeetDisgust
researchProduct

Copper radiopharmaceuticals for theranostic applications

2018

The growing advancement in nuclear medicine challenges researchers from several different fields to integrate imaging and therapeutic modalities in a theranostic radiopharmaceutical, which can be defined as a molecular entity with readily replaceable radioisotope to provide easy switch between diagnostic and therapeutic applications for efficient and patient-friendly treatment of diseases. For such a reason, the diagnostic and therapeutic potential of all five medical radionuclides of copper have thoroughly been investigated as they boost the hope for development of successful radiotheranostics. To facilitate the mutual understanding between all different specialists working on this multidi…

PharmacologyDose-Response Relationship DrugMolecular StructureChemistryOrganic ChemistryPersonalized treatmentNanotechnology02 engineering and technologyGeneral Medicine010402 general chemistry021001 nanoscience & nanotechnologyBiocompatible material01 natural sciencesTheranostic NanomedicineTherapeutic modalities0104 chemical sciencesStructure-Activity RelationshipCopper RadioisotopesDrug DiscoveryAnimalsHumansRadiopharmaceuticals0210 nano-technologyMolecular entityEuropean Journal of Medicinal Chemistry
researchProduct

In vivo stimulation of murine haematopoiesis by the antineoplastic agent bryostatin-1

1990

PharmacologyDrugDose-Response Relationship DrugBryostatin 1ChemistryInjections Subcutaneousmedia_common.quotation_subjectMice Inbred StrainsStimulationPharmacologyBryostatinsHematopoietic Stem CellsAntineoplastic Agents PhytogenicHematopoiesisLactonesMiceBryostatinsHaematopoiesisDose–response relationshipInbred strainIn vivoAnimalsFemaleMacrolidesmedia_commonPharmacological Research
researchProduct

Salvage treatment with ganciclovir in a splenectomized, polytransfused patient affected by systemic inflammatory response syndrome

2014

A 23-year-old man was admitted to hospital with a 12-day history of daily fever. A clinical history revealed that 10 months previously, the patient had been splenectomized and polytransfused for a severe blunt trauma. On admission, laboratory data revealed significant leukocytosis (33,230/ul). The patient's general clinical conditions rapidly worsened into a severe systemic inflammatory response syndrome in four days. After 10 days of broad-spectrum antibiotic treatment, the temperature curve was unmodified and severe leukocytosis persisted (44,300 ul) with absolute lymphocytosis. Laboratory tests ruled out hematological diseases, pneumonia, abscesses and endocarditis. In the light of IgM …

PharmacologyGanciclovirmedicine.medical_specialtySettore MED/09 - Medicina Internamedicine.drug_classbusiness.industryImmunologyAntibioticsSalvage treatmentmedicine.diseaseGastroenterologySystemic inflammatory response syndromePneumoniaBlunt traumaInternal medicineAnesthesiamedicineImmunology and AllergyEndocarditisganciclovirinflammatory responseLeukocytosismedicine.symptombusinessmedicine.drug
researchProduct

The Antibody Response to the BNT162b2 mRNA COVID-19 Booster in Healthcare Workers: Association between the IgG Antibody Titers and Anthropometric and…

2022

Background: Research shows that in most people, two-dose vaccination helps to shape the humoral response to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Further studies are required to learn about the vaccine’s effectiveness after boosting. Methods: We conducted a prospective study among 103 healthcare workers (HCWs) from a regional multi-specialty hospital vaccinated with three doses of the BNT162b2 vaccine. We compared their immunoglobulin G (IgG) titers 14 days after the second dose with those 21 days after the booster. We also compared their anthropometric and body composition parameters with IgG concentrations at the same time points. Results: Twenty-one days aft…

PharmacologyInfectious DiseasesDrug DiscoveryImmunologyPharmacology (medical)IgG antibody; SARS-CoV-2; COVID-19; healthcare workers; humoral response; COVID-19 vaccine; BNT162b2 vaccine; immunization; body composition; boosterVaccines; Volume 10; Issue 10; Pages: 1638
researchProduct

Evidence of a flip-flop phenomenon in acamprosate pharmacokinetics: an in vivo study in rats.

2006

The pharmacokinetics of acamprosate were examined in the rat after oral and intravenous administration in order to detect the possible presence of a flip-flop phenomenon. Rats received 9.3 or 73.3 mg/kg of the drug as an intravenous bolus. The same doses were orally administered via gastric intubation. Plasma samples were taken from the jugular vein for determination of acamprosate concentration by liquid scintillation counting. The drug content was also quantified in urine and faeces. The acamprosate bioavailability was close to 20%, the amount recovered in the faeces being around 80% of the administered dose. The terminal slope of the oral plasma curve was significantly lower than that ob…

PharmacologyMaleDose-Response Relationship DrugChemistryTaurineAcamprosateDrug Administration RoutesPharmaceutical ScienceGeneral MedicineAbsorption (skin)UrinePharmacologyBioavailabilityRatsDose–response relationshipAcamprosatePharmacokineticsIn vivoOral administrationmedicineAnimalsPharmacology (medical)Rats Wistarmedicine.drugAlcohol DeterrentsBiopharmaceuticsdrug disposition
researchProduct

Synthesis and anti-staphylococcal activity of new 4-diazopyrazole derivatives.

2012

Abstract Several new 4-diazopyrazole derivatives 6a – g and 9a – c were obtained by the reaction of 1-(R-substituted-phenyl)-3-(1,3-dimethyl-1 H -pyrazol-5-yl)ureas 5a – g and N -(1,3-dimethyl-1 H -pyrazol-5-yl)-2-(R-substituted-phenyl)acetamides 8a – c respectively with a sevenfold excess of nitrous acid in acetic acid solution. The compounds were assayed for their activity against the Staphylococcus aureus reference strains ATCC 25923, ATCC 29213 and ATCC 6538, as well as six veterinary strains. The best anti-staphylococcal profile was showed by [(R-substituted-phenyl)acetyl](4-diazonio-1,3-dimethyl-1 H -pyrazol-5-yl)azanides 9a , c . Compound 9c was also able at 3.1 μg mL −1 to inhibit o…

PharmacologyNitrous acidStaphylococcus aureusDose-Response Relationship DrugMolecular StructureStereochemistryOrganic ChemistryBiofilmGeneral MedicineMicrobial Sensitivity Testsmedicine.disease_causeSettore BIO/19 - Microbiologia GeneraleSettore CHIM/08 - Chimica FarmaceuticaAnti-Bacterial Agentschemistry.chemical_compoundStructure-Activity RelationshipchemistryStaphylococcus aureusBiofilmsDrug DiscoverymedicinePyrazolesAcetic acid solution4-diazopyrazoles anti-staphylococcal activity anti-biofilm activityAzo CompoundsEuropean journal of medicinal chemistry
researchProduct

Therapeutic monitoring of new antipsychotic drugs.

2004

Typical antipsychotic drugs qualify for therapeutic drug monitoring (TDM) primarily for the following reasons: control of compliance and avoidance of extrapyramidal side effects by keeping chronic exposure to minimal effective blood levels. For the atypical antipsychotic clozapine, drug safety is another reason to use TDM. With regard to the new antipsychotics risperidone, olanzapine, quetiapine, amisulpride, ziprasidone, and aripiprazole, which have been introduced in the clinic during the last few years, the rationale to use TDM is a matter of debate. Positron emission tomography (PET), which enables measurement of the occupancy of dopamine D2 receptors, revealed that receptor occupancy c…

PharmacologyOlanzapinemedicine.diagnostic_testDose-Response Relationship Drugmedicine.drug_classbusiness.industryReceptors Dopamine D2medicine.medical_treatmentAtypical antipsychoticPharmacologyTypical antipsychoticStructure-Activity RelationshipTherapeutic drug monitoringmedicineQuetiapineHumansPharmacology (medical)ZiprasidoneAmisulprideDrug MonitoringAntipsychoticbusinessmedicine.drugAntipsychotic AgentsTherapeutic drug monitoring
researchProduct

Evaluation of the effectiveness of drug prevention programs: Analysis of the international scientific production (2002–2011)

2015

s / Drug and Alcohol Dependence 146 (2015) e202–e284 e205 Oxytocin effects on human aggressive responding Joseph L. Alcorn, Nadeeka Dias, N. Rathnayaka, Joy Schmitz, C. Green, Scott D. Lane Department of Psychiatry & Behavioral Sciences, School of Medicine, Program in Neuroscience, Graduate School of Biomedical Sciences, University of Texas Health Science Center – Houston, Houston, TX, United States Aims: In the search for interventions aimed at improving the social functioning of individuals with substance use disorders (SUD), the neuropeptide oxytocin (OT) and the oxytonergic system may hold promise as an intervention strategy for promoting prosocial behaviors. Acute administration of OT …

PharmacologyResponse rate (survey)medicine.medical_specialtyAggressionPsychological interventionScopusBehavioural sciencesToxicologymedicine.diseaselanguage.human_languageSubstance abusePsychiatry and Mental healthProsocial behaviormedicinelanguagePharmacology (medical)medicine.symptomPortuguesePsychiatryPsychologyDrug and Alcohol Dependence
researchProduct